期刊文献+

PCI围手术期强化阿托伐他汀钙治疗对ACS患者炎症反应和内皮功能的影响 被引量:2

下载PDF
导出
摘要 目的观察不同剂量阿托伐他汀钙对经皮冠状动脉介入治疗(PCI)围手术期的急性冠状动脉综合征(ACS)患者炎症反应和血管内皮功能的影响。方法将50例拟行PCI术的ACS患者随机分为两组各25例:A组给予阿托伐他汀钙20 mg·d-1;B组给予阿托伐他汀钙80 mg·d-1,疗程均为1周。B组于PCI术前2 h加服阿托伐他汀钙40 mg,两组其余干预措施相同。分别测定两组入院时、PCI术前(治疗1周)、PCI术后48 h血清高敏C反应蛋白(hsCRP)、一氧化氮(NOS)合酶等水平。结果①两组hs-CRP浓度变化:PCI术前与入院时相比均明显降低,B组降低更显著,差异有统计学意义(P<0.05);PCI术后较术前显著升高,A组升高明显,差异有统计学意义(P<0.05);②两组NOS浓度变化:PCI术前与入院时相比明显升高,其中B组升高更显著,差异有统计学意义(P<0.05);PCI术后较术前均明显降低,A组降低更显著,差异有统计学意义(P<0.05)。结论 PCI围手术期强化阿托伐他汀钙治疗可减轻PCI术后炎症反应,改善血管内皮功能。
出处 《医药导报》 CAS 北大核心 2014年第7期906-908,共3页 Herald of Medicine
基金 国家自然科学基金资助项目(30860102) 四川省卫生厅资助课题(120472)
  • 相关文献

参考文献11

  • 1HEDSTROM E, ASTROM-OLSSON K, OHLIN A K, et al. Initial results of inflammatory response, matrix remodeling, and reactive oxygen species following PCI in acute ischemic myocardial injury in man [ J ]. J Invasive Cardiol, 2011,23 (9) :371-376. 被引量:1
  • 2BALLANTYNE C M, PITT B, LOSCALZO J, et al. Alteration of relation of atherogenic lipoprotein cholesterol to apolipo-protein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [ LUNAR ] Trial) [ J ]. Am J Cardiol,2013,111 (4) :506-509. 被引量:1
  • 3DI SCIASCIO G, PATTI G, PASCERI V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J]. J Am Coil Cardiol,2009,54(6) :558-565. 被引量:1
  • 4HALVORSEN S, SELJEFLOT I, WEISS T, et al. Inflam- matory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy [ J ]. Thromb Res, 2012,130 ( 3 ) :495-500. 被引量:1
  • 5陈力,贺巧云,凌文革,匡希斌.急性心肌梗死患者直接PCI术后血管内皮功能的变化及其临床意义[J].广东医学院学报,2008,26(4):404-406. 被引量:2
  • 6HIBI K, KIMURA T, KIMURA K, et al. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial [ J ]. Atherosclerosis, 2011,219 ( 2 ) :743-749. 被引量:1
  • 7KIM Y R, PARK J H,LEE H J, et al. The effect of doubling the statin dose on pro-inflammatory cytokine in patients with triple-vessel coronary artery disease [ J ]. Korean Circ J, 2012,42 (9) :595-599. 被引量:1
  • 8LAUFS U, LA FATA V, PLUTZKY J, et al. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors [ J ]. Circulation, 1998,97 ( 12 ) : 1129-1135. 被引量:1
  • 9MASHIMO Y, ISHIKAWA T, NUMAKURA M, et al. Critical promo-ter region for statin-indueed human endothelial nitric oxide synthase (eNOS) transcription in EA. hy926 cells [ J ]. J Atheroscler Thromb, 2013,20 ( 4 ) : 321-329. 被引量:1
  • 10PEDERSEN T R, FAERGEMAN O, KASTELEIN J J, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study : a randomized controlled trial [ J ]. JAMA, 2005,294 (19) :2437-2445. 被引量:1

二级参考文献5

  • 1范海荣,孙福成.炎症与动脉粥样硬化的研究进展[J].中华老年医学杂志,2004,23(12):893-895. 被引量:21
  • 2赵令时(摘).急性心肌梗死直接血管成形术后ST段抬高的决定因素和预后,微血管再灌注损伤的临床价值.国外医学:心血管疾病分册,2000,27(1):55-56. 被引量:1
  • 3De Lemos J A, Antman E M, Gibson C M, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction[J]. Circulation,2000,101(3) :239-243. 被引量:1
  • 4Viles-Gonzalez J F, Anand S X, Zafar M U, et al. Tissue factor coagulation pathway: a new therapeutic target in atherothrombosis[J]. J Cardiovasc Pharmacol, 2004,43 (5) : 669-676. 被引量:1
  • 5Grybauskas P. Role of tissue factor in athemthrombosis [ J ]. Medicina (Kaunas) ,2003,39(12) : 1165-1170. 被引量:1

共引文献1

同被引文献42

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部